Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 06 06 2020
accepted: 17 09 2020
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 1 12 2020
Statut: epublish

Résumé

To prevent gastric cancer, it is important to accurately determine the presence of Helicobacter pylori (HP) infection. However, correctly identifying HP-uninfected individuals is difficult when using the combination of HP antibody and pepsinogen (PG). The aim of this study was to discriminate true HP-uninfected individuals from others without the need for endoscopic examination. A total of 684 subjects with no history of HP eradication who underwent a medical checkup at our hospital were enrolled. The "true uninfected individuals" were determined by a negative stool antigen test and no endoscopic findings of HP-associated gastritis. HP antibody was measured by the latex immunoassay method. Logistic regression analysis using a combination of noninvasive parameters was performed to develop a formula for predicting true uninfected individuals. A total of 528 subjects were classified as true uninfected individuals. Logistic regression analysis showed that statistically significant factors for true uninfected individuals were age (p < 0.001), HP antibody (p <0.001), PGI (p <0.001), and PGII (p = 0.012). The areas under the curve (AUCs) for true uninfected individuals were the highest (0.944) upon applying the prediction formula including four parameters: age, HP antibody, PGI, and PGII. Both the sensitivity and the specificity of the four-parameter prediction formula were higher than those of the traditional three-parameter model using HP antibody, PGI, and PGI/II ratio (sensitivity: 93.2% vs. 86.6% and specificity: 88.5% vs. 82.7%). Our findings suggest that a model with a combination of four noninvasive parameters is useful for predicting true HP-uninfected individuals without the need for endoscopic examination.

Identifiants

pubmed: 33002056
doi: 10.1371/journal.pone.0240040
pii: PONE-D-20-17227
pmc: PMC7529238
doi:

Substances chimiques

Antibodies, Bacterial 0
Pepsinogen A 9001-10-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0240040

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Gut. 2001 Mar;48(3):287-9
pubmed: 11171812
PLoS One. 2014 Oct 14;9(10):e109783
pubmed: 25314140
Scand J Gastroenterol. 1989 Sep;24(7):870-6
pubmed: 2799289
Digestion. 2017;95(3):229-236
pubmed: 28355604
APMIS. 2003 Jun;111(6):619-24
pubmed: 12969017
Digestion. 2016;93(1):13-8
pubmed: 26789514
Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2117-24
pubmed: 22354521
J Gastroenterol. 2018 Aug;53(8):924-931
pubmed: 29353347
Gut. 2015 Sep;64(9):1353-67
pubmed: 26187502
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405-14
pubmed: 21785258
Helicobacter. 2004 Aug;9(4):335-41
pubmed: 15270748
Gastroenterology. 1991 Jul;101(1):167-74
pubmed: 2044906
Sci Rep. 2017 Nov 14;7(1):15491
pubmed: 29138514
Helicobacter. 2014 Feb;19(1):1-8
pubmed: 24215601
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Am J Gastroenterol. 2006 Aug;101(8):1921-30
pubmed: 16780557
Digestion. 2017;95(4):314-318
pubmed: 28571035

Auteurs

Takako Takayama (T)

Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Tsukuba, Japan.

Hideo Suzuki (H)

Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Tsukuba, Japan.
The Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Kosuke Okada (K)

Tsukuba Preventive Medical Research Center, University of Tsukuba Hospital, Tsukuba, Japan.

Takeshi Yamada (T)

The Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Kazushi Maruo (K)

Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Yoko Saito (Y)

Ibarakiken Medical Center, Mito, Japan.

Yuji Mizokami (Y)

The Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH